ERAS RSI Chart
Last 7 days
5.0%
Last 30 days
-8.7%
Last 90 days
11.2%
Trailing 12 Months
-28.0%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 15, 2023 | chacko david m. | acquired | 11,886 | 1.5895 | 7,478 | cfo and cbo |
Dec 15, 2023 | garner ebun | acquired | 8,659 | 1.5895 | 5,448 | general counsel & corp. sec. |
Dec 06, 2023 | start valerie denise harding | bought | 18,480 | 1.848 | 10,000 | - |
Dec 06, 2023 | lim jonathan e | bought | 478,418 | 1.72 | 278,150 | chairman & ceo |
Dec 05, 2023 | lim jonathan e | bought | 1,217,760 | 1.687 | 721,850 | chairman & ceo |
Dec 04, 2023 | casdin alexander w. | bought | 49,785 | 1.6595 | 30,000 | - |
Oct 05, 2023 | lim jonathan e | bought | 2,026,000 | 2.026 | 1,000,000 | chairman & ceo |
Jun 08, 2023 | lim jonathan e | bought | 275,000 | 2.75 | 100,000 | chairman & ceo |
Apr 10, 2023 | casdin alexander w. | bought | 55,230 | 2.7615 | 20,000 | - |
Mar 28, 2023 | lim jonathan e | bought | 284,000 | 2.84 | 100,000 | chairman & ceo |
Which funds bought or sold ERAS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | Lindbrook Capital, LLC | sold off | -100 | -3,557 | - | -% |
Apr 25, 2024 | Zurcher Kantonalbank (Zurich Cantonalbank) | sold off | -100 | -64,049 | - | -% |
Apr 25, 2024 | SIMPLEX TRADING, LLC | added | 195 | 6,000 | 9,000 | -% |
Apr 25, 2024 | Aaron Wealth Advisors LLC | added | 107 | 28,660 | 57,134 | 0.01% |
Apr 25, 2024 | Allworth Financial LP | added | 331 | 1,960 | 2,578 | -% |
Apr 25, 2024 | Bank of New York Mellon Corp | reduced | -7.92 | -65,998 | 536,962 | -% |
Apr 23, 2024 | AMALGAMATED BANK | reduced | -65.23 | -9,000 | 5,000 | -% |
Apr 22, 2024 | MetLife Investment Management, LLC | unchanged | - | 5,964 | 79,400 | -% |
Apr 19, 2024 | DENALI ADVISORS LLC | unchanged | - | -6,384 | 187,872 | 0.06% |
Apr 18, 2024 | EDBI Pte Ltd | unchanged | - | -62,222 | 1,831,110 | 2.06% |
Unveiling Erasca, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Erasca, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 41.2B | 6.8B | -8.75 | 6.02 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.0B | 1.8B | -41 | 9.87 | ||||
BMRN | 15.4B | 2.5B | 74.73 | 6.21 | ||||
INCY | 11.6B | 3.7B | 19.41 | 3.14 | ||||
MID-CAP | ||||||||
APLS | 6.0B | 396.6M | -11.37 | 15.16 | ||||
BBIO | 4.4B | - | -6.7 | 60.35 | ||||
AXSM | 3.4B | 270.6M | -14.22 | 12.57 | ||||
ACAD | 2.8B | 726.4M | -44.9 | 3.79 | ||||
ARWR | 2.7B | 240.7M | -9.23 | 12.18 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 24.58 | 4.41 | ||||
NVAX | 569.6M | 983.7M | -1.05 | 0.58 | ||||
CRBP | 361.2M | 881.7K | -8.1 | 466.16 | ||||
INO | 247.0M | 4.9M | -1.83 | 50.76 | ||||
IBIO | 6.1M | 2.1M | -0.22 | 2.14 |
Erasca, Inc. News
Balance Sheet | |||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | -5.7% | 395 | 419 | 441 | 468 | 515 | 446 | 445 | 475 | 501 | 522 | 210 | 125 |
Current Assets | 4.8% | 321 | 306 | 324 | 398 | 444 | 366 | 381 | 403 | 420 | 492 | 197 | 120 |
Cash Equivalents | -17.5% | 93.00 | 113 | 139 | 273 | 284 | 219 | 219 | 333 | 360 | 446 | 156 | 65.00 |
Net PPE | -3.9% | 22.00 | 23.00 | 24.00 | 25.00 | 25.00 | 25.00 | 24.00 | 20.00 | 16.00 | 9.00 | 2.00 | 2.00 |
Liabilities | -2.3% | 79.00 | 80.00 | 78.00 | 81.00 | 103 | 81.00 | 50.00 | 51.00 | 45.00 | 39.00 | 20.00 | 17.00 |
Current Liabilities | -2.1% | 26.00 | 27.00 | 23.00 | 26.00 | 49.00 | 28.00 | 22.00 | 21.00 | 26.00 | 20.00 | 18.00 | 14.00 |
Shareholder's Equity | -6.6% | 317 | 339 | 363 | 386 | 412 | 365 | 395 | 425 | 457 | 483 | - | - |
Retained Earnings | -5.2% | -606 | -576 | -546 | -514 | -480 | -345 | -310 | -274 | -238 | -207 | -161 | -115 |
Additional Paid-In Capital | 0.7% | 923 | 916 | 909 | 901 | 894 | 712 | 707 | 700 | 695 | 691 | 12.00 | 1.00 |
Shares Outstanding | 0.4% | 151 | 151 | 150 | 150 | 149 | 121 | 120 | 119 | 119 | 99.00 | 23.00 | 22.00 |
Float | - | - | - | 297 | - | - | - | 432 | - | - | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Cashflow From Operations | -2.8% | -24,788 | -24,120 | -25,951 | -26,358 | -26,372 | -23,945 | -27,141 | -25,806 | -22,482 | -23,219 | -18,233 | -15,666 | - | - | - |
Share Based Compensation | -1.6% | 6,136 | 6,238 | 7,012 | 6,845 | 5,380 | 5,232 | 5,055 | 4,442 | 2,883 | 3,017 | 1,636 | 795 | - | - | - |
Cashflow From Investing | 350.8% | 4,545 | -1,812 | -108,667 | 14,714 | -4,867 | -55,229 | -9,191 | -1,794 | -63,949 | -4,939 | 4,460 | -162 | - | - | - |
Cashflow From Financing | 6414.3% | 456 | 7.00 | 649 | 183 | 96,196 | 427 | 992 | 460 | 1,107 | 317,573 | 180 | 120,537 | - | - | - |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating expenses: | ||
Research and development | $ 103,821 | $ 112,457 |
In-process research and development | 102,000 | |
General and administrative | 37,704 | 32,993 |
Total operating expenses | 141,525 | 247,450 |
Loss from operations | (141,525) | (247,450) |
Other income (expense) | ||
Interest income | 16,712 | 4,902 |
Other expense, net | (229) | (257) |
Total other income (expense), net | 16,483 | 4,645 |
Net loss | $ (125,042) | $ (242,805) |
Net loss per share, basic | $ (0.83) | $ (1.99) |
Net loss per share, diluted | $ (0.83) | $ (1.99) |
Weighted-average shares of common stock used in computing net loss per share, basic | 150,184,994 | 122,024,848 |
Weighted-average shares of common stock used in computing net loss per share, diluted | 150,184,994 | 122,024,848 |
Other comprehensive income (loss): | ||
Unrealized gain (loss) on marketable securities, net | $ 1,118 | $ (879) |
Comprehensive loss | $ (123,924) | $ (243,684) |
Consolidated Balance Sheets - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 93,075,000 | $ 284,217,000 |
Short-term marketable securities | 219,275,000 | 151,403,000 |
Prepaid expenses and other current assets | 8,326,000 | 8,876,000 |
Total current assets | 320,676,000 | 444,496,000 |
Long-term marketable securities | 9,642,000 | |
Property and equipment, net | 22,327,000 | 24,815,000 |
Operating lease assets | 37,861,000 | 40,418,000 |
Restricted cash | 408,000 | 408,000 |
Other assets | 4,383,000 | 4,772,000 |
Total assets | 395,297,000 | 514,909,000 |
Current liabilities: | ||
Accounts payable | 2,000,000 | 23,049,000 |
Accrued expenses and other current liabilities | 20,186,000 | 24,336,000 |
Operating lease liabilities | 3,970,000 | 1,305,000 |
Total current liabilities | 26,156,000 | 48,690,000 |
Operating lease liabilities, net of current portion | 51,889,000 | 53,793,000 |
Other liabilities | 566,000 | 573,000 |
Total liabilities | 78,611,000 | 103,056,000 |
Commitments and contingencies (Note 12) | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value; 80,000,000 shares authorized at December 31, 2023 and 2022; no shares issued and outstanding at December 31, 2023 and 2022 | ||
Common stock, $0.0001 par value; 800,000,000 shares authorized at December 31, 2023 and 2022; 151,462,103 and 150,448,363 shares issued at December 31, 2023 and 2022, respectively; 151,090,227 and 149,333,258 shares outstanding at December 31, 2023 and 2022, respectively | 15,000 | 15,000 |
Additional paid-in capital | 922,607,000 | 893,850,000 |
Accumulated other comprehensive income (loss) | 77,000 | (1,041,000) |
Accumulated deficit | (606,013,000) | (480,971,000) |
Total stockholders' equity | 316,686,000 | 411,853,000 |
Total liabilities and stockholders' equity | $ 395,297,000 | $ 514,909,000 |